Verastem (VSTM) EBT Margin Growth (3y) (2021 - 2024)

Verastem (VSTM) EBT Margin Growth (3y) (2021 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,237.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -408.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 677,188.00
Mar 31, 2022 161,798.00
Dec 31, 2021 2,596.00
Sep 30, 2021 -124.69 Mn
Jun 30, 2021 -642,959.00